NO971934L - Flourinerte vitamin D3 -analoger - Google Patents

Flourinerte vitamin D3 -analoger

Info

Publication number
NO971934L
NO971934L NO971934A NO971934A NO971934L NO 971934 L NO971934 L NO 971934L NO 971934 A NO971934 A NO 971934A NO 971934 A NO971934 A NO 971934A NO 971934 L NO971934 L NO 971934L
Authority
NO
Norway
Prior art keywords
analogues
fluorinated vitamin
disorders
hydroxyl
hydrogen
Prior art date
Application number
NO971934A
Other languages
English (en)
Norwegian (no)
Other versions
NO971934D0 (no
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO971934D0 publication Critical patent/NO971934D0/no
Publication of NO971934L publication Critical patent/NO971934L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO971934A 1996-05-23 1997-04-25 Flourinerte vitamin D3 -analoger NO971934L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (2)

Publication Number Publication Date
NO971934D0 NO971934D0 (no) 1997-04-25
NO971934L true NO971934L (no) 1997-11-24

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971934A NO971934L (no) 1996-05-23 1997-04-25 Flourinerte vitamin D3 -analoger

Country Status (30)

Country Link
US (1) US5888994A (ja)
EP (1) EP0808831B1 (ja)
JP (1) JP2858571B2 (ja)
KR (1) KR100237523B1 (ja)
CN (1) CN1081184C (ja)
AR (1) AR007240A1 (ja)
AT (1) ATE195514T1 (ja)
AU (1) AU720098B2 (ja)
BR (1) BR9703373A (ja)
CA (1) CA2204478C (ja)
CO (1) CO4840512A1 (ja)
CZ (1) CZ157997A3 (ja)
DE (1) DE69702812T2 (ja)
DK (1) DK0808831T3 (ja)
ES (1) ES2150719T3 (ja)
GR (1) GR3034832T3 (ja)
HR (1) HRP970274A2 (ja)
HU (1) HUP9700927A3 (ja)
IL (1) IL120842A0 (ja)
MA (1) MA24345A1 (ja)
NO (1) NO971934L (ja)
NZ (1) NZ314838A (ja)
PL (1) PL320131A1 (ja)
PT (1) PT808831E (ja)
SG (1) SG50831A1 (ja)
TR (1) TR199700418A2 (ja)
TW (1) TW374762B (ja)
UY (1) UY24563A1 (ja)
YU (1) YU19997A (ja)
ZA (1) ZA974334B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
EP0981514B1 (en) * 1997-05-16 2006-04-05 Woman & Infants Hospital 3-epi vitamin d2 compounds and uses thereof
US6100294A (en) * 1997-05-16 2000-08-08 Women And Infants Hospital Cyclic ether vitamin D3 compounds, 1α(OH) 3-epi-vitamin D3 compounds and uses thereof
JP4219553B2 (ja) * 1997-09-08 2009-02-04 エフ.ホフマン−ラ ロシュ アーゲー 1,3−ジヒドロキシ−20,20−ジアルキル−ビタミンd3類似体
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
JP2008519808A (ja) 2004-11-12 2008-06-12 ビオエクセル エスピーエー 膀胱癌治療のためのビタミンd誘導体及び抗増殖薬の併用
CA2882048C (en) 2006-02-03 2020-03-24 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
DK3357496T3 (da) 2006-06-21 2020-05-11 Opko Ireland Global Holdings Ltd Terapi ved brug af vitamin d-repletteringsmiddel og vitamin d-hormonsubstitutionsmiddel
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 d 부족 및 결핍의 치료 방법
ES2956794T3 (es) 2007-04-25 2023-12-28 Eirgen Pharma Ltd Liberación controlada de 25-hidroxivitamina D
EP3636280A1 (en) 2010-03-29 2020-04-15 Opko Ireland Global Holdings, Ltd. Methods and compositions for reducing parathyroid levels
US8754067B2 (en) 2010-11-12 2014-06-17 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
KR20180123100A (ko) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
ES2091515T3 (es) * 1992-05-20 1996-11-01 Hoffmann La Roche Analogos fluorados de la vitamina d3.
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
TW267161B (ja) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
TW374762B (en) 1999-11-21
NZ314838A (en) 1998-01-26
BR9703373A (pt) 1998-09-15
NO971934D0 (no) 1997-04-25
HUP9700927A2 (hu) 1998-01-28
JPH1045712A (ja) 1998-02-17
UY24563A1 (es) 2000-12-29
CZ157997A3 (en) 1997-12-17
HUP9700927A3 (en) 1999-07-28
PL320131A1 (en) 1997-11-24
DE69702812D1 (de) 2000-09-21
MX9703776A (es) 1998-06-30
DE69702812T2 (de) 2001-01-25
EP0808831A3 (en) 1999-02-03
YU19997A (sh) 1999-07-28
CO4840512A1 (es) 1999-09-27
ZA974334B (en) 1997-11-24
KR970074763A (ko) 1997-12-10
PT808831E (pt) 2000-12-29
EP0808831B1 (en) 2000-08-16
IL120842A0 (en) 1997-09-30
CA2204478C (en) 2006-11-21
HU9700927D0 (en) 1997-07-28
KR100237523B1 (ko) 2000-01-15
HRP970274A2 (en) 1998-04-30
CN1169425A (zh) 1998-01-07
SG50831A1 (en) 1998-07-20
ES2150719T3 (es) 2000-12-01
MA24345A1 (fr) 1998-07-01
JP2858571B2 (ja) 1999-02-17
DK0808831T3 (da) 2001-01-02
US5888994A (en) 1999-03-30
TR199700418A3 (tr) 1997-12-21
CA2204478A1 (en) 1997-11-23
CN1081184C (zh) 2002-03-20
GR3034832T3 (en) 2001-02-28
AU2357297A (en) 1997-11-27
AU720098B2 (en) 2000-05-25
TR199700418A2 (xx) 1997-12-21
AR007240A1 (es) 1999-10-27
EP0808831A2 (en) 1997-11-26
ATE195514T1 (de) 2000-09-15

Similar Documents

Publication Publication Date Title
NO971934L (no) Flourinerte vitamin D3 -analoger
NO972304L (no) Vitamin D3-analoger
GB2102287B (en) Use of aromatase-inhibitors with antiandrogens for treatment of prostatic hyperplasia.
NO983266L (no) Distribuert Behandling
HU9301361D0 (en) Method for producing 4-aryl-piperazines and 4-aryl-piperidines
HK56897A (en) Benzocyclobutyl-or indanyl-alkyl-amino-alkyl substituted 3-benzazepin-2-ones useful in the treatment of cardiovascular diseases
GR3036455T3 (en) Atherosclerosis treatment
AU4588489A (en) Hypocholesterolemic and antiatherosclerotic uses of bis(3,5-di-tertiary-4-hydroxyphenylthio)methane
ID24308A (id) Plasma darah yang dapat diaplikasikan secara universal
ATE141914T1 (de) Fluorierte analoge vitamins d3
MX9703024A (es) Cristalizacion de levobupivacaina y sus analogos.
DE3476847D1 (en) A remedial or prophylactic agent for the treatment of seizures
NO934197L (no) Vitamin D-3-analoger
ECSP972130A (es) Analogos de vitamina d3 - fluorinados
GR3034688T3 (en) Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
TW224489B (ja)
MX9207565A (es) Hidroxilacion.
RU2072690C1 (ru) Штамм бактерий morganella morganii - продуцент термолабильного энтеротоксина
ECSP972129A (es) Analogos de vitamina d3
MD259C2 (ro) Metodă de tratament al maladiei ulceroase a duodenului, complicată cu stenoză piloroduodenală
GR1003147B (el) Συσκευη εκτιμησης ελαστικοτητας του αρτηριακου τοιχωματος
UA28323A (uk) Спосіб лікування нейроциркуляторної дистонії